Home Assessment and Initiation of Antiretroviral Therapy for HIV in Malawi

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

16660 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-01-31

Study Completion Date

2013-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Despite increasing availability of antiretroviral therapy (ART) for HIV in high prevalence countries, the majority of people with HIV infection still initiate treatment at an advanced stage of disease. This leads to a high risk of death soon after HIV diagnosis. Prompt HIV diagnosis is, therefore, necessary for both individual and public health benefit and is being strongly promoted as international and national policy in Malawi. However timely HIV diagnosis may not in itself be sufficient to ensure ART initiation: this is reflected by the relatively high proportion of individuals who defer treatment-seeking for months or years following diagnosis of HIV.

Here the researchers investigate the extent to which home assessment and initiation of ART adds to the effectiveness of a home-based HIV testing and counseling strategy, using entry to, adherence with, and retention in HIV care as the outcome of interest.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Reduction of EArly mortaLITY in HIV-infected Adults and Children Starting Antiretroviral Therapy

NCT01825031

Human Immunodeficiency Virus

COMPLETED PHASE3

The Impact of Home Delivery of Antiretroviral Therapy on Virological Suppression

NCT02711293

HIV Community Health Workers Antiretroviral Therapy, Highly Active

COMPLETED NA

Comparison of Facility and Home-based ART Delivery Systems in Uganda

NCT00144365

AIDS

COMPLETED PHASE3

Efficacy Study of Different Laboratory Management Strategies and Drug Regimens in HIV-infected Children in Africa

NCT02028676

Human Immunodeficiency Virus

COMPLETED PHASE4

Engaging Informal Health Care Providers on Case Detection and Treatment Initiation Rates for TB and HIV in Rural Malawi (Triage Plus)

NCT02127983

Tuberculosis HIV

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

HIV

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Home assessment and initiation of ART

Participants with a positive home-based HIV test result will receive a home visit from a study nurse who will complete the following on the first home visit:

* Confirmatory fingerprick HIV testing
* TB symptom screening
* ART eligibility assessment (Word Health Organization clinical staging, sampling of blood for measurement of CD4 count and treatment education)

At a second home visit (within 5 days), participants who are ART eligible (as defined in National ART guidelines) will be initiated onto ART (using National Treatment Programme ART regimens).

Following home initiation of ART, participants in the intervention arm will receive detailed counselling from the study nurse about the need to attend their first 2-week follow-up appointment at the primary health care clinic that serves their household's residence. They will receive a referral slip detailing the date, time and place of their appointment.

Group Type EXPERIMENTAL

Home assessment and initiation of ART

Intervention Type OTHER

Home-based ART eligibility assessment (WHO staging, CD4 count measurement and educational treatment preparation) and initiation.

Clinic-based ART assessment and initiation

Participants who meet eligibility criteria and reside in a cluster that has been allocated to the control arm of this study will receive supported access to ART care through the primary care system for confirmation of HIV status and entry into HIV following disclosure to the resident community counsellor. HIV care, including ART, will be started from the primary care clinic.

Group Type OTHER

Clinic-based ART assessment and initiation

Intervention Type OTHER

Participants who meet eligibility criteria and reside in a cluster that has been allocated to the control arm of this study will receive supported access to ART care through the primary care system for confirmation of HIV status and entry into HIV following disclosure to the resident community counsellor.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Home assessment and initiation of ART

Home-based ART eligibility assessment (WHO staging, CD4 count measurement and educational treatment preparation) and initiation.

Intervention Type OTHER

Clinic-based ART assessment and initiation

Participants who meet eligibility criteria and reside in a cluster that has been allocated to the control arm of this study will receive supported access to ART care through the primary care system for confirmation of HIV status and entry into HIV following disclosure to the resident community counsellor.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Usual resident of an eligible cluster
* Has had a positive HIV test (regardless of source) and requests facilitated access to HIV care from the resident community counsellor
* Confirmatory HIV test is positive
* No previous ART treatment, or less than one month's treatment in the past (including PMTCT interventions) and not currently receiving HIV care
* No contraindications to receiving ART (as defined by Integrated Management of Adult Illnesses, HIV Department, WHO)
* No acute danger signs requiring hospital referral
* Aged 18 years or older
* Written or witnessed informed consent to participate in the study

Exclusion Criteria

* Not a usual resident of an eligible cluster
* No previous HIV test, or HIV infection not confirmed by home-based ART nurse
* Already receiving ART, or has had more than 1 month's treatment in the past
* Known contraindication to firstline ART (known hypersensitivity, renal failure, chronic liver disease)
* Acute danger sign present (as defined by Integrated Management of Adult Illnesses, HIV Department, WHO)
* Age younger than 18 years
* Not willing to accept home-based ART initiation

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No